skip to Main Content

Expert Outlines Clinical Implications of Precision Medicine in GI Cancers

Newsfeed image, light gray text on dark gray background
Regarding precision medicine in gastrointestinal (GI) cancers, pathologists are working to determine which patient populations should undergo which molecular tests.

In a presentation during the 2018 OncLive® State of the Science Summit™ on Gastrointestinal Cancers, Shirley Michelle Shiller, DO, a pathologist at Baylor University Medical Center, discussed the clinical application of precision medicine in GI cancer. Read more. . .


Back To Top